Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654509 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine
A Phase 2 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 2
- Development phase
- 138
- Enrollment target
NCT02654509 is a Phase 2 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 138 participants.
The verdict
NCT02654509, a Phase 2 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 138 participants
- Enrollment target
Study Summary
This study is being conducted to collect safety and immunogenicity data for the Eastern Equine Encephalitis (EEE) vaccine.
Interventions
- BIOLOGICAL Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2008-06-03 |
| Est. Completion | 2018-03-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02654509
The ClinicalTrials.gov registry entry for NCT02654509 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104 is the first listed.
NCT02654509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02654509 about?
NCT02654509 is a clinical study titled "Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine". This study is being conducted to collect safety and immunogenicity data for the Eastern Equine Encephalitis (EEE) vaccine.
What is the current status of trial NCT02654509?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 138 participants. The study started on 2008-06-03. Estimated completion is 2018-03-18.
What interventions are being tested in trial NCT02654509?
The interventions under investigation include: Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02654509?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.